Hap Trading, LLC Vyne Therapeutics Inc. Transaction History
Hap Trading, LLC
- $1.06 Trillion
- Q2 2025
A detailed history of Hap Trading, LLC transactions in Vyne Therapeutics Inc. stock. As of the latest transaction made, Hap Trading, LLC holds 21,400 shares of VYNE stock, worth $7,918. This represents 0.0% of its overall portfolio holdings.
Number of Shares
21,400Holding current value
$7,918% of portfolio
0.0%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding VYNE
# of Institutions
4Shares Held
52.2KCall Options Held
0Put Options Held
0-
Staley Capital Advisers Inc51.5KShares$19,0440.0% of portfolio
-
Fortitude Family Office, LLC Scottsdale, AZ680Shares$2510.0% of portfolio
-
Farther Finance Advisors, LLC San Francisco, CA16Shares$50.0% of portfolio
-
Concourse Financial Group Securities, Inc. Birmingham, AL0Shares$0100.0% of portfolio
About VYNE Therapeutics Inc.
- Ticker VYNE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 58,005,600
- Market Cap $21.5M
- Description
- VYNE Therapeutics Inc., a pharmaceutical company, focuses on developing various therapeutics for the treatment of immuno-inflammatory conditions. The company develops FCD105, a topical combination foam that has completed Phase III clinical trials for the treatment of moderate-to-severe acne vulgaris; and FMX114, a combination of tofacitinib, whi...